NewHavenBIZ

22 n e w h a v e n B I Z | J u l y 2 0 2 2 | n e w h a v e n b i z . c o m ©2022 CliftonLarsonAllen LLP. Investment advisory services are offered through CliftonLarsonAllen Wealth Advisors, LLC, an SEC-registered investment advisor. CPAs | CONSULTANTS | WEALTH ADVISORS Shelton 203-944-2100 CLAconnect.com We'll get you there. Where is your there? CLA brings balance to get you where you want to go. medical engineering professors and construction of a new Physical Science & Engineering Building that will likely be Yale's largest building investment ever. "Since our founding in 2003, SEAS has built an international reputation in the areas of drug delivery, medical imaging, and tissue engineering," Gonzalez said. "So this investment will strengthen an already strong department, while enhancing visibility and the national standing of SEAS and Yale overall." Fairfield University's Balaji and Mark Saltzman, pro- fessor of clinical and biomedical engineering at Yale, said the recent program expansions are the result of a real-world need to hasten discovery of new healthcare products and technologies for diagnosis and treatment. "It really doesn't take a long time to make a big change to our biomedical engineering program," Balaji said. "If what we want to do has merit, the university is quick to prioritize and act on it." Other local universities that have biomedical engi- neering programs include the University of Bridgeport and University of New Haven. Quinnipiac University has a biomedical science program that is slightly differ- ent; its emphasis is almost exclusively on research, as opposed to the creation of new devices and techniques. UConn also has a strong foothold in the field focused on three specialized areas: regenerative engineering, biosensors (which is related to artificial intelligence) and neuroscience. UConn biomedical engineering professor Ki Chon says federal research grants help advance the school's work and brandish its reputation. e same is true at Yale. "Our students get to work on real-life problems," Chon said. e schools also assist with internships and by seeking research partnerships with local companies that can provide additional opportunities for student participation. Many students from Fairfield, Yale and UConn intern with one of several local biomedical engineering firms, such as Medtronic, PerkinElmer and Singleron Biotechnologies. A number of students end up as em- ployees following graduation, school officials said. Singleron founder and CEO Nan Fang said her company is always in search of new talent and works to recruit from local schools. "We always try to find internships," added omas Martin, professor and chair of the biomedical sciences department at Quinnipiac. "And now that we're com- ing out of COVID, we're exploring many new partner- ships with regional biomedical companies." n Continued from page 21 PHOTO | CONTRIBUTED Nan Fang is the founder and CEO of Singleron Biotechnologies in Woodbridge. PHOTO | CONTRIBUTED Singleron Biotechnologies is a molecular diagnostic company.

• Cover